Carmen Luisa Loureiro

Carmen Luisa Loureiro

Auto-generated profile, based on publicly available information

Carmen Luisa Loureiro

Laboratorio de Virología Molecular, Centro de Microbiología y Biología Celular, Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2007 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
MDM. Devesa
M. Devesa
CLC.L. Loureiro
C.L. Loureiro
YRY. Rivas
Y. Rivas
FMF. Monsalve
F. Monsalve
NCN. Cardona
N. Cardona
Flor H  PujolFlor H Pujol
Flor H Pujol
The objective of this study was the evaluation of the genetic diversity found in HBV circulating among Venezuelan Amerindians and the general population in Colombia. Phylogenetic analysis of the S region in 194 isolates showed that genotype F is highly predominant in Colombia and Venezuela. This might be related to the genetic background of the population. F3 is the main subgenotype which circulates in both countries. Phylogenetic analysis of 61 complete genome sequences of HBV American genotypes confirms the presence of two genotypes F and H, and 4 F subgenotypes. In Venezuela, subgenotypes F1, F2, and F3 circulate in East and West Amerindians, while only F3 was found among South Amerindians. Japreira community derived from Yucpa Amerindians around 150 years ago. However, several Japreira HBV sequences were forming a clade that can be classified as subgenotype 2b, differing from Yucpa sequences that belong mainly to subgenotype F3. The apparent absence of correlation between the phylogenetic groupings of HBV isolates with the ethnical origin in aboriginal populations might be suggesting a recent origin of HBV American subgenotypes, or a genetic drift effect. J. Med. Virol. 80:20–26, 2008.

31 May 2001 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
AQAlberto Quintero
Alberto Quintero
NUNathalie Uzcátegui
Nathalie Uzcátegui
CLCarmen Luisa Loureiro
Carmen Luisa Loureiro
LVLeopolodo Villegas
Leopolodo Villegas
XIXimena Illarramendi
Ximena Illarramendi
Flor H  PujolFlor H Pujol
Flor H Pujol

13 December 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMaria Z. Sulbarán
Maria Z. Sulbarán
FLFederico A. Di Lello
Federico A. Di Lello
YSYoneira Sulbarán
Yoneira Sulbarán
CCClarisa Cosson
Clarisa Cosson
CLCarmen L. Loureiro
Carmen L. Loureiro
Flor H  PujolFlor H Pujol
Flor H Pujol
The subtype diversity of the hepatitis C virus (HCV) genotypes is unknown in Venezuela. Partial sequencing of the NS5B region was performed in 310 isolates circulating in patients from 1995 to 2007. In the samples collected between 2005 and 2007, HCV genotype 1 (G1) was the most common genotype (63%), composed as expected of mainly G1a and G1b. G2 was the second most common genotype (33%), being G2a almost absent and G2j the most frequent subtype. Sequence analysis of the core region confirmed the subtype assignment performed within the NS5b region in 63 isolates. The complete genome sequence of G2j was obtained. G2j has been described in France, Canada and Burkina Fasso, but it was not found in Martinique, where several subtypes of G2 circulate in the general population. Bayesian coalescence analysis indicated a most recent common ancestor (MRCA) of G2j around 1785, before the introduction of G1b (1869) and G1a (1922). While HCV G1a and G1b experienced a growth reduction since 1990, coincident with the time when blood testing was implemented in Venezuela, HCV G2j did not seem to reach growth equilibrium during this period. Assuming the introduction of G2j from Africa during the slave trade, the high frequency of G2j found in Venezuela could suggest: 1- the introduction of African ethnic groups different from the ones introduced to Martinique or 2- the occurrence of a founder effect. This study represents an in-depth analysis of the subtype diversity of HCV in Venezuela, which is still unexplored in the Americas and deserves further studies.

17 July 2013 in AIDS
Verified
Journal Article
Closed access
JVJulian A. Villalba
Julian A. Villalba
GBGonzalo Bello
Gonzalo Bello
MMMailis Maes
Mailis Maes
YSYoneira F. Sulbaran
Yoneira F. Sulbaran
DGDomingo Garzaro
Domingo Garzaro
Flor H  PujolFlor H Pujol
Flor H Pujol
We previously reported HIV-1 infection in Warao Amerindians from Venezuela. The aim of this study was to evaluate the extent and the dynamic of HIV-1 dissemination in eight Warao communities. HIV-1 infection was evaluated in 576 Warao Amerindians from the Orinoco Delta. Partial HIV-1 pol sequences were analyzed to reconstruct the spatiotemporal and demographic dynamics of the epidemic. HIV-1 antibodies were present in 9.55% of Warao Amerindians, ranging from 0 to 22%. A significantly higher prevalence was found in men (15.6%) compared with women (2.6%), reaching up to 35% in men from one community. All but one isolates were classified as subtype B. Warao's HIV-1 subtype-B epidemic resulted from a single viral introduction at around the early 2000s. After an initial phase of slow growth, the subtype B started to spread at a fast rate (0.8/year) following two major routes of migration within the communities. A dramatic high prevalence was documented in almost all the communities of Warao Amerindians from the Orinoco Delta tested for HIV-1 infection. This epidemic resulted from the dissemination of a single HIV-1 subtype B founder strain introduced about 10 years ago and its size is probably doubling every year, creating a situation that can be devastating for this vulnerable Amerindian group.

26 April 2004 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
CGCristina Gutiérrez
Cristina Gutiérrez
MDMarisol Devesa
Marisol Devesa
CLCarmen Luisa Loureiro
Carmen Luisa Loureiro
GLGraciela León
Graciela León
FLFerdinando Liprandi
Ferdinando Liprandi
Flor H  PujolFlor H Pujol
Flor H Pujol

21 September 2012 in Virology Journal
Verified
Journal Article
Open access
PDF file
RJRossana C Jaspe
Rossana C Jaspe
YGYoneira Fabiola Sulbaran Garcia
Yoneira Fabiola Sulbaran Garcia
MSMaria Z Sulbarán
Maria Z Sulbarán
CLCarmen L Loureiro
Carmen L Loureiro
HRHector Rafael Rangel
Hector Rafael Rangel
Flor H  PujolFlor H Pujol
Flor H Pujol
Background: Recent reports show that R70Q and L/C91M amino acid substitutions in the core from different hepatitis C virus (HCV) genotypes have been associated with variable responses to interferon (IFN) and ribavirin (RBV) therapy, as well to an increase of hepatocellular carcinoma (HCC) risk, liver steatosis and insulin resistance (IR). Mutations in NS5B have also been associated to IFN, RBV, nucleoside and non-nucleoside inhibitors drug resistance. The prevalence of these mutations was studied in HCV RNA samples from chronically HCV-infected drug-naïve patients. Methods: After amplification of core and NS5B region by nested-PCR, 12 substitutions were analyzed in 266 Venezuelan HCV isolates subtype 1a, 1b, 2a, 2c, 2b, 2j (a subtype frequently found in Venezuela) and 3a (n = 127 and n = 228 for core and NS5B respectively), and compared to isolates from other countries (n = 355 and n = 646 for core and NS5B respectively). Results: R70Q and L/C91M core substitutions were present exclusively in HCV G1b. Both substitutions were more frequent in American isolates compared to Asian ones (69% versus 26%, p < 0.001 and 75% versus 45%, p < 0.001 respectively). In Venezuelan isolates NS5B D310N substitution was detected mainly in G3a (100%) and G1a (13%), this later with a significantly higher prevalence than in Brazilian isolates (p = 0.03). The NS5B mutations related to IFN/RBV treatment D244N was mainly found in G3a, and Q309R was present in all genotypes, except G2. Resistance to new NS5B inhibitors (C316N) was only detected in 18% of G1b, with a significantly lower prevalence than in Asian isolates, where this polymorphism was surprisingly frequent (p < 0.001). Conclusions: Genotypical, geographical and regional differences were found in the prevalence of substitutions in HCV core and NS5B proteins. The substitutions found in the Venezuelan G2j type were similar to that found in G2a and G2c isolates. Our results suggest a high prevalence of the R70Q and L/C91M mutations of core protein for G1b and D310N substitution of NS5B protein for the G3a. C316N polymorphism related with resistance to new NS5B inhibitors was only found in G1b. Some of these mutations could be associated with a worse prognosis of the disease in HCV infected patients.